ICON debuts new service for cardiology studies

Dublin, Ireland-based ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, says that its Medical Imaging division has become the first commercial imaging core laboratory to offer Quantitative Coronary Angiographic (QCA) analysis with an integrated electronic Case Report Form.

This new service has been made possible through the integration of QCAPlus, a QCA application from Sanders Data Systems, with an eCRF within ICON Medical Imaging's proprietary Medical Image Review and Analysis system. The integration of QCAPlus adds to the existing visualization, analysis and project management applications currently available through MIRA.

"Clinical trials incorporating QCA have made a significant impact in cardiovascular drug and device development," commented Jonathan Goldman, chief medical officer at ICON Medical Imaging. "Building QCA capabilities into MIRA represents the latest in a series of innovations designed to boost the integrity and reproducibility of clinical trial data, and enhances our leadership in the field of imaging within clinical research," he noted.